Friday 6 November 2026 Export DHR’s income statement to Excel — free account

Danaher Corporation

DHR Healthcare Diagnostics & Research

Danaher Corporation’s revenue for fiscal 2025 (year ended December 2025) was $24.6 billion, up 2.90% from fiscal 2024.

Revenue: +8.28%
EPS: +36.7%
Free cash flow: +19.1%
Total debt: +44.9%

Quarter to September 2026, against a year earlier

S&P 500

229.53 3.19 +1.41%

Follow DHR

Alert me

Market cap: $159.2B
P/E: 37.0×
Fwd P/E: 36.9×
Dividend yield: 0.67%
F-score: 6/9
Altman Z: 4.52
Beneish M: −2.57
Dividend safety: 69/100

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Danaher Corporation 10-Q filed Oct 21, 2025

Fiscal Q3 2025 · Period ended Sep 26, 2025 · Filed Oct 21, 2025 · accepted 5:56 PM ET · Document on sec.gov · Filing index

What changed

Part I, Item 2, Management’s Discussion and Analysis Part II, Item 1A, Risk Factors

Part II, Item 1A, Risk Factors, against the 10-Q filed Jul 22, 2025: 1 modified